Pseudotumor cerebri surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 12: Line 12:
* hypotesion<ref name="pmid2679506">{{cite journal |vauthors=Corbett JJ, Thompson HS |title=The rational management of idiopathic intracranial hypertension |journal=Arch. Neurol. |volume=46 |issue=10 |pages=1049–51 |date=October 1989 |pmid=2679506 |doi= |url=}}</ref>
* hypotesion<ref name="pmid2679506">{{cite journal |vauthors=Corbett JJ, Thompson HS |title=The rational management of idiopathic intracranial hypertension |journal=Arch. Neurol. |volume=46 |issue=10 |pages=1049–51 |date=October 1989 |pmid=2679506 |doi= |url=}}</ref>
==Surgery==
==Surgery==
Surgical options are:


==Contraindications==
==== Optic nerve sheath fenestration ====
In IIH patients with papilledema, optic nerve sheath fenestration (ONSF) can improve visual loss.(3)
 
==== Shunting ====
Ventriculoperitoneal and lumboperitoneal shunting can reduce headaches, diplopia, papilledema and visual loss in IIH patients.(3-61-81-86)
 
==== Venous sinus stenting ====
We can perform venous stenting in patients with venous sinus stenosis on cerebral venography. This method can reduce headaches and visual problems.(99-100)


==References==
==References==

Revision as of 15:26, 30 July 2018

Pseudotumor cerebri Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating pseudotumor cerebri from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudotumor cerebri surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudotumor cerebri surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudotumor cerebri surgery

CDC on Pseudotumor cerebri surgery

Pseudotumor cerebri surgery in the news

Blogs on Pseudotumor cerebri surgery

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Pseudotumor cerebri surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Indications

Surgery is not the first-line treatment option for patients with pseudotumor cerebri. Surgery is usually reserved for patients with either:

  • Progress of visual field loss despite medical treatment with maximum dosage
  • Visual acuity loss which is the result of papilledema
  • Resistant headache
  • hypotesion[1]

Surgery

Surgical options are:

Optic nerve sheath fenestration

In IIH patients with papilledema, optic nerve sheath fenestration (ONSF) can improve visual loss.(3)

Shunting

Ventriculoperitoneal and lumboperitoneal shunting can reduce headaches, diplopia, papilledema and visual loss in IIH patients.(3-61-81-86)

Venous sinus stenting

We can perform venous stenting in patients with venous sinus stenosis on cerebral venography. This method can reduce headaches and visual problems.(99-100)

References

  1. Corbett JJ, Thompson HS (October 1989). "The rational management of idiopathic intracranial hypertension". Arch. Neurol. 46 (10): 1049–51. PMID 2679506.

Template:WH Template:WS